|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 102.6 USD | +0.61% |
|
-2.85% | +2.71% |
| 07:26am | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
| Apr. 16 | Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing | MT |
Oct 14 (Reuters) - A panel of expert advisers to the U.S. Food and Drug Administration voted on Thursday to recommend booster shots of Moderna Inc's COVID-19 vaccine for Americans aged 65 and older and those at high risk of severe illness. (Reporting by Manas Mishra in Bengaluru; Editing by Leslie Adler)
| 1st Jan change | Capi. | |
|---|---|---|
| +2.71% | 39.05B | |
| -1.53% | 41.35B | |
| +42.15% | 40.38B | |
| -12.11% | 26.67B | |
| +1.96% | 24.07B | |
| -23.58% | 18.36B | |
| -3.56% | 11.68B | |
| +21.15% | 11.6B | |
| +7.60% | 11.15B | |
| -19.10% | 9.78B |
MODERNA, INC. 
